Infection of placenta left in situ therapy

doi:10.3877/cma.j.issn.2095-3259.2017.03.004

Abstract

Abstract:

With the increasing of cesarean section rate and the importance of preserving the reproductive function, placenta left in situ in the treatment of placenta implantation has been highlighted, and a series of problems have been brought. This article discusses the generality and therapy of placenta implantation, particularly about the infection issue of placenta left in situ.

Key words: Placenta accreta, Placenta, retained, Complications, infectious

Xiaochun Yi, Jianping Zhang. Infection of placenta left in situ therapy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2017, 06(03): 142-146.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2017.03.004

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2017/V06/I03/142

References 27

[1]	Belfort MA. Placenta accrete[J]. Am J Obstet Gynecol, 2010, 203(5):430-439.
[2]	Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study[J]. Plos One, 2012, 7(12):e52893.
[3]	陈敦金，苏春宏. 胎盘植入[M]．长沙：湖南科技出版社，2013: 2.
[4]	Wortman AC, Alexander JM. Placenta accreta, increta, and percreta[J]. Obstet Gynecol Clin North Am, 2013, 40(1):137-154.
[5]	Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 27: Placenta praevia, placenta praevia accreta andvasa praevia: diagnosis and management [R]. London: RCOG, 2011: 1-26.
[6]	Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accrete[J]. Obstet Gynecol, 2006, 108(3 Pt 1):573.
[7]	Jaraquemada JMP, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings[J]. Acta Obstetricia Et Gynecologica Scandinavica, 2009, 85(3):378-379.
[8]	Kanal E, Barkovich AJ, Bell C, et al. ACR Blue Ribbon Panel on MR Safety. ACR guidance document for safe MR practices: 2007[J]. AJR Am J Roentgenol, 2007, 188(6):1447-1474.
[9]	陈敦金，杨慧霞. 胎盘植入诊治指南(2015)[J]. 中华妇产科杂志，2015, 50(12):26-31.
[10]	Ganchimeg T, Nagata C, Vogel JP, et al. Optimal timing of delivery among low-risk women with prior caesarean section: A secondary analysis of the WHO multicountry survey on maternal and newborn health[J]. Plos One, 2017, 11(2):e0149091.
[11]	Committee on Obstetric Practice. Committee opinion no. 529: placenta accrete[J]. Obstet Gynecol, 2012, 120(1):207-211.
[12]	Smith DD, Perez-Delboy A, Burke WM, et al. Buttock necrosis after uterine artery embolization for delayed hysterectomy in placenta percreta[J]. Case Rep Obstet Gynecol, 2016, 2016:6921280.
[13]	Pereira N, Elias RT, Gunnala V, et al. Sonographic, Hysteroscopic, and Histopathological Findings of a Placental Site Nodule[J]. J Minim Invasive Gynecol, 2017, 24(6):891-892.
[14]	Khan M, Sachdeva P, Arora R, et al. Conservative management of morbidly adherant placenta—A case report and review of literature[J]. Placenta, 2013, 34(10):963-966.
[15]	Wong VV, Burke G. Planned conservative management of placenta percreta[J]. J Obstet Gynaecol, 2012, 32(5):447-452.
[16]	Clausen C, Langhoffroos J. Management of placenta percreta: a review of published cases[J]. Acta Obstet Gynecol Scand, 2014, 93(2):138-143.
[17]	Chibueze EC, Parsons AJQ, Ota E, et al. Prophylactic antibiotics for manual removal of retained placenta during vaginal birth: a systematic review of observational studies and meta-analysis[J]. BMC Pregnancy and Childbirth, 2015, 15(1):313.
[18]	Promberger R, Ott J, Chalubinski KM. Ten-Year Experience with the Conservative Management of Abnormally Invasive, Residual Trophoblastic Disease. A Retrospective Case Series[J]. Gynecol Obstet Invest, 2016, 81(4):375-380.
[19]	Chabrot P, Diop AN, Boyer L, et al. Maternal outcome after conservative treatment of placenta accrete[J]. Obstet Gynecol, 2010, 116(5):1219-1221.
[20]	Gupta D, Sinha R. Management of placenta accreta with oral methotrexate[J]. Int J Gynaecol Obstet, 1998, 60(2):171-173.
[21]	Clément D, Kayem G, Cabrol D. Conservative treatment of placenta percreta: a safe alternative[J]. Eur J Obstet Gynecol Reprod Biol, 2004, 114(1):108-109.
[22]	Mechery J, Burch D. Alternative management of placenta accrete[J]. Gynecological Surgery, 2006, 3(1):41-42.
[23]	Hunt JC. Conservative management of placenta accreta in a multiparous woman[J]. J Pregnancy, 2010, 2010:329618.
[24]	Târcomnicu IM, Dimitriu MCT, Cãlin RA, et al. Case report pregnancy with an increased obstetrical risk. placenta accreta. Trends[J]. Archives of the Balkan Medical Union, 2016, 51(2):273-278.
[25]	Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation[J]. Obstet Gynecol Surv, 2007, 62(8):529-539.
[26]	Kayem G, Deneuxtharaux C, Sentilhes L. Paccreta: clinical situations at high risk of placenta ACCRETA/percreta: impact of diagnostic methods and management on maternal morbidity[J]. Acta Obstet Gynecol Scand, 2013, 92(4):476-482.
[27]	Collins SL, Ashcroft A, Braun T, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP)[J]. Ultrasound Obstet Gynecol, 2016, 47(3):271-275.

Please choose a citation manager

Content to export